超越人类表皮生长因子受体-2 的食管胃癌靶向药物

IF 2.5 3区 医学 Q2 HEMATOLOGY
Eric Mehlhaff MD , Devon Miller MD , Johnathan D. Ebben MD, PhD , Oleksii Dobrzhanskyi MD , Nataliya V. Uboha MD, PhD
{"title":"超越人类表皮生长因子受体-2 的食管胃癌靶向药物","authors":"Eric Mehlhaff MD , Devon Miller MD , Johnathan D. Ebben MD, PhD , Oleksii Dobrzhanskyi MD , Nataliya V. Uboha MD, PhD","doi":"10.1016/j.hoc.2024.02.006","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":55060,"journal":{"name":"Hematology-Oncology Clinics of North America","volume":"38 3","pages":"Pages 659-675"},"PeriodicalIF":2.5000,"publicationDate":"2024-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Targeted Agents in Esophagogastric Cancer Beyond Human Epidermal Growth Factor Receptor-2\",\"authors\":\"Eric Mehlhaff MD , Devon Miller MD , Johnathan D. Ebben MD, PhD , Oleksii Dobrzhanskyi MD , Nataliya V. Uboha MD, PhD\",\"doi\":\"10.1016/j.hoc.2024.02.006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":55060,\"journal\":{\"name\":\"Hematology-Oncology Clinics of North America\",\"volume\":\"38 3\",\"pages\":\"Pages 659-675\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-03-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hematology-Oncology Clinics of North America\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0889858824000236\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology-Oncology Clinics of North America","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0889858824000236","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

胃食管癌是一种在解剖学和分子特征方面高度多样化的肿瘤,这使得药物开发具有挑战性。最近,人们在了解这些癌症的分子特征方面取得了进展,发现了一些新的生物标志物。目前正在进行的临床试验正在研究新的靶向药物,并取得了可喜的成果。CLDN18.2已成为一种生物标志物,具有相关靶向疗法的既定活性。其他靶向药物,如贝马单抗和 DKN-01 也在积极研究中。随着新药被纳入治疗方案,生物标志物重叠、肿瘤异质性和毒性管理等问题将需要得到解决。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Targeted Agents in Esophagogastric Cancer Beyond Human Epidermal Growth Factor Receptor-2
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
86
审稿时长
6-12 weeks
期刊介绍: Hematology/Oncology Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Under the direction of an experienced guest editor, each issue focuses on a single topic in hematology and oncology, including hemostasis and thrombosis, molecular and cellular basis of hematology, coagulation disorders, and cancers—bone, gastrointestinal, head and neck, lymphomas, neuroendocrine, breast, renal cell, melanoma, and more.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信